King's College London

Research portal

Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies

Research output: Contribution to journalArticlepeer-review

Surabhi Nanda, George Nikoletakis, Desislava Markova, Leona Poon, Kypros Nicolaides

Original languageEnglish
Article numberN/A
Pages (from-to)814-819
Number of pages6
JournalMetabolism: clinical and experimental
Volume62
Issue number6
DOIs
PublishedJun 2013

King's Authors

Abstract

OBJECTIVE:
To examine maternal serum levels of retinol-binding protein-4 (RBP4) at 11-13 weeks' gestation in normal and pathological pregnancies.

METHODS:
Serum RBP4 at 11-13 weeks was measured in 480 singleton pregnancies, including 240 with normal outcome, 60 that subsequently developed preeclampsia (PE), 60 that developed gestational diabetes mellitus (GDM), 60 that delivered large for gestational age (LGA) neonates and 60 that delivered small (SGA) neonates. The values in each adverse pregnancy outcome group were compared to those of normal pregnancies.

RESULTS:
Serum concentration of RBP4 was not significantly different in women who subsequently developed PE (p=0.925), or GDM (p=0.074), or had pregnancies that led to delivery to SGA (p=0.085), LGA (p=0.332) neonates.

CONCLUSION:
Maternal serum RBP4 in the first trimester is not significantly altered in pathological pregnancies.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454